Integra LifeSciences Holdings Corporation (IART)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Integra LifeSciences Holdings Corporation, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Integra LifeSciences Holdings Corporation (IART) has returned -24.15% so far this year and -57.16% over the past 12 months. Over the last ten years, IART has returned -11.98% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Aug 16, 1995, IART's average daily return is +0.07%, while the average monthly return is +1.18%. At this rate, your investment would double in approximately 4.9 years.

Historically, 53% of months were positive and 47% were negative. The best month was Feb 2000 with a return of +99.1%, while the worst month was Jul 1996 at -48.7%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 6 months.

On a daily basis, IART closed higher 49% of trading days. The best single day was Mar 10, 1997 with a return of +41.7%, while the worst single day was Jul 29, 1996 at -30.6%.

Integra LifeSciences Holdings Corporation has an annualized alpha of 9.83%, beta of 0.72, and R² of 0.07 versus S&P 500 Index. Calculated based on daily prices since August 17, 1995.

• This stock participated in 112.21% of S&P 500 Index downside but only 88.93% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.07 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

IART ranks 7 for risk / return — in the bottom 7% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for Integra LifeSciences Holdings Corporation (IART) and compare them to a chosen benchmark (S&P 500 Index).

Integra LifeSciences Holdings Corporation provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.

The table displays the monthly dividend distributions for Integra LifeSciences Holdings Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Integra LifeSciences Holdings Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Integra LifeSciences Holdings Corporation was 88.39%, occurring on Mar 18, 2026. The portfolio has not yet recovered.

The current Integra LifeSciences Holdings Corporation drawdown is 87.71%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Integra LifeSciences Holdings Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Integra LifeSciences Holdings Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.